AGAPE ATP Corporation (ATPC), a NASDAQ-listed company, through its subsidiary AGAPE Superior Living Sdn. Bhd (ASL), proudly launched the enhanced version of its flagship wellness supplement, ATP2. This scientifically advanced product addresses critical health challenges like aging, metabolism, and chronic disease management, positioning itself as a holistic solution for improving energy, health, and overall vitality.
ATPC aims to sell 5,000 units by year-end, driven by ATP2’s unique blend of plant-based enzymes, minerals, amino acids, and hydrogen acetate technology. The company expects high demand as consumers increasingly seek natural health solutions.
Dr. Fernando Cortizo, President of ASL’s Research and Development Team, emphasized ATP2’s potential: “The future of nutrition lies in reversing chronic diseases and aging. ATP2 embodies this vision, offering a powerful mix of enzymes, minerals, and amino acids to tackle a variety of health concerns. It boosts energy by enhancing Nicotinamide Adenine Dinucleotide (NADH+) levels.”
The enhanced formula integrates plant-based enzymes, 76 essential minerals, 20 amino acids, and hydrogen acetate to improve metabolism, reduce inflammation, and reverse aging effects. It enhances cellular health, regulates bodily functions, and promotes long-term vitality.
Prof Dato’ Sri Dr. How Kok Choong, Founder and Global Group CEO of ATPC, highlighted ATP2’s benefits: “ATP2 manages blood pressure and blood sugar, supports cardiovascular health, and promotes gut flora. Its anti-aging properties enhance cellular repair and reduce oxidative stress, helping users maintain youthful energy.”
Locally manufactured in Malaysia with advanced technologies from Australia, the USA, Europe, and Japan, ATP2 ensures superior quality while meeting growing consumer demand.
Aligned with the UN Sustainable Development Goals (UNSDG) for health and well-being, ATP2 offers a scientifically backed solution to common health concerns, reaffirming ATPC’s leadership in sustainable wellness innovations.